June 28, 2017
Arix Bioscience rasies $45M for its branch focused on gene therapies for orphan paediatric diseases
Arix Bioscience has raised $45 million by a Series B financing round for LogicBio Therapeutics, a new Arix Group Business focused on gene therapies for orphan paediatric diseases.